Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-0.06%
operating margin TTM
1.62%
revenue TTM
425.72 Million
revenue per share TTM
3.31$
valuation ratios | |
|---|---|
| pe ratio | -1,084.47 |
| peg ratio | 1.72 |
| price to book ratio | 0.81 |
| price to sales ratio | 0.60 |
| enterprise value multiple | 8.16 |
| price fair value | 0.81 |
profitability ratios | |
|---|---|
| gross profit margin | 69.1% |
| operating profit margin | 1.62% |
| pretax profit margin | 0.99% |
| net profit margin | -0.06% |
| return on assets | -0.05% |
| return on equity | -0.07% |
| return on capital employed | 1.88% |
liquidity ratios | |
|---|---|
| current ratio | 3.53 |
| quick ratio | 3.16 |
| cash ratio | 1.21 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 65.27 |
| operating cycle | 148.21 |
| days of payables outstanding | 65.71 |
| cash conversion cycle | 82.50 |
| receivables turnover | 4.40 |
| payables turnover | 5.55 |
| inventory turnover | 5.59 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.19 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.16 |
| interest coverage | 12.82 |
| cash flow to debt ratio | 0.43 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.13 |
| cash per share | 0.72 |
| operating cash flow per share | 0.24 |
| free cash flow operating cash flow ratio | 0.56 |
| cash flow coverage ratios | 0.43 |
| short term coverage ratios | 3.16 |
| capital expenditure coverage ratio | 2.25 |
Frequently Asked Questions
When was the last time Organogenesis Holdings Inc. (NASDAQ:ORGO) reported earnings?
Organogenesis Holdings Inc. (ORGO) published its most recent earnings results on 07-05-2026.
What is Organogenesis Holdings Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Organogenesis Holdings Inc. (NASDAQ:ORGO)'s trailing twelve months ROE is -0.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Organogenesis Holdings Inc. (ORGO) currently has a ROA of -0.05%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ORGO's net profit margin stand at?
ORGO reported a profit margin of -0.06% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ORGO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.53 in the most recent quarter. The quick ratio stood at 3.16, with a Debt/Eq ratio of 0.19.